FDA approves first interchangeable biosimilar insulin product for treatment of diabetes
- Details
- Category: FDA

FDA approves first oral blood thinning medication for children
- Details
- Category: FDA

FDA grants accelerated approval for Alzheimer's drug
- Details
- Category: FDA

FDA approves new drug treatment for chronic weight management, first since 2014
- Details
- Category: FDA

FDA authorizes additional monoclonal antibody for treatment of COVID-19
- Details
- Category: FDA

FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic
- Details
- Category: FDA

FDA and CDC lift recommended pause on Johnson & Johnson (Janssen) COVID-19 vaccine use following thorough safety review
- Details
- Category: FDA

More Pharma News ...
- FDA revokes emergency use authorization for monoclonal antibody Bamlanivimab
- Joint CDC and FDA statement on Johnson & Johnson COVID-19 vaccine
- AstraZeneca's COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
- Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna
- EMA's safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events
- EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU
- EMA starts rolling review of the Sputnik V COVID-19 vaccine